(Bloomberg) -- Iran has started ramping up its oil production and expects to reach pre-sanctions levels in one to two months, Deputy Oil Minister Amir Hossein Zamaninia said.The oil market will be able to accommodate Iran’s maximum oil output of around 3.9 million to 4 million barrels a day, Zamaninia told reporters on the sidelines of an oil conference in Tehran on Friday. Subject to punitive U.S. sanctions, the country is barely pumping around half that amount currently, according to Bloomberg data.Iran has been subject to tough U.S. sanctions since 2018, when the administration of then-President Donald Trump unilaterally withdrew from an international deal that restricted the Middle Eastern country’s nuclear activities.President Joe Biden is expected to seek the restoration of that accord and officials in Tehran have expressed the hope he will ease restrictions on its petroleum sales. But for now, the sanctions are still in place and any buyer of Iranian crude would face the same legal and financial penalties that have deterred most potential customers over the past few years.Zamaninia declined to specify the current level of Iran’s oil exports, but said the numbers were “much better than many assume,” while Oil Minister Bijan Namdar Zanganeh said shipments have increased “dramatically.” Oil analysts viewed the announcements with skepticism.“I find this premature,” said Eugen Weinberg, head of commodities research at Commerzbank AG in Frankfurt. “Possible buyers of Iranian oil are likely to wait for an agreement, and an end of the sanctions.”Sharply DownOutput stood at 1.99 million barrels a day in December, down by almost 50% compared with the months before Trump’s move, according to Bloomberg estimates. Many Iranian oil tankers switched off their transponders soon after the measures were announced, making it harder to quantify the impact on exports. Biden’s Treasury Secretary nominee Janet Yellen said Thursday that the U.S. would only provide sanctions relief if Iran resumed its commitments under the nuclear deal.Tehran, which has been ramping up its nuclear activity in defiance of U.S. pressure, has said it wouldn’t restore its compliance until sanctions are lifted. Announcing strong export levels and ambitious targets could be part of the negotiating process.Kpler Ltd., a market intelligence firm, said that Iran’s recovery will depend on three elements: the readiness of Biden to reactivate the nuclear deal, the country’s technical ability to revive production, and the willingness of customers to resume purchases.“Iran has demonstrated in the past a very strong ability to bring oil back to the market, although we think that one-to-two months is very optimistic,” said Alex Booth, Kpler’s head of research.China already showed some readiness to continue purchases from Iran even at the height of sanctions, and Indian customers could return too, Booth said. Production cuts by Iran’s counterparts in OPEC+, such as Saudi Arabia, may have created a gap for the Islamic Republic to fill, he added.Oil Minister Bijan Namdar Zanganeh said in December that the government sought to double oil production and increase exports to 2.3 million barrels a day.Zamaninia, who is also Iran’s OPEC governor, said Tehran had been discussing energy projects, including upstream projects and oil purchases, over the past several weeks with European and Asian companies.“Iran’s bold claims on recovering oil exports in weeks don’t really stand up to scrutiny,” said Bill Farren-Price, a director at research firm Enverus. “But it does show that Iran is keen to test the U.S. commitment to the sanctions. Tehran just put nuclear diplomacy back on the front burner.”(Updates with analyst comments in 7th to 10th and final paragraphs.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Apple is said to be working on a new version of the MacBook Air with a brand new physical case design that's both thinner and lighter than its current offering, which was updated with Apple's M1 chip late last year, per a new Bloomberg report. The plan is to release it as early as late 2021 or 2022, according to the report's sources, and it will also include MagSafe charging (which is also said to be returning on Apple's next MacBook Pro models sometime in 2021). MagSafe would offer power delivery and charging, while two USB 4 ports would provide data connectivity on the new MacBook Air.
Largest directory of trusted, highly-segmented information on 91,000 practicing physicians and 10,000 residents and nurse practitionersVANCOUVER, British Columbia, Jan. 22, 2021 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a telehealth company revolutionizing the delivery of healthcare to patients, is pleased to announce that it has closed the previously announced acquisition of Canadian Medical Directory (“CMD”), Canada’s largest, most trusted, directory of medical professionals including 91,000 practicing physicians and 10,000 residents and nurse practitioners across the country. The robust, multi-layered database is genuinely unique as no other direct competitor has a SaaS platform that collects and vends the data in such a highly segmented, up-to-date way. CMD has been trusted as the gold standard for up-to-date information on all medical professionals across Canada in a standard national format. CMD is Canada’s leading source for profile and contact information on practicing physicians, specialists and nurse practitioners, across the country. It’s a key reference tool used by clinics, hospitals, medical placement firms, pharmaceutical companies, and manufacturers and distributors of medical equipment and supplies. CloudMD will be able to integrate the CMD database into its Juno EMR, billing, virtual care and telehealth platforms, as well as iMD Health’s leading educational resource databank. CloudMD will leverage the CMD brand, customer network and data, to power up and accelerate doctor acquisition and adoption. In addition, CloudMD will use its suite of products and resources to continue building and growing CMD’s robust database. CMD generated approximately $450,000 in high margin, 100% SaaS based revenues with earnings before interest, taxes, depreciation and amortization (EBITDA) margins exceeding 65%, resulting in an EBITDA of approximately $293,000 over the 12 month period ending September 30, 2020. The Company believes that there is significant opportunity to further optimize the revenue through integration and optimization. Terms of Agreement In consideration for the purchase of 100% of the assets and business of CMD, CloudMD has agreed to pay aggregate consideration of approximately $2.037 million payable as follows: (i) $250,000 in cash; (ii) approximately $1.42 million in shares of the Company; and (iii) a performance-based earnout of $368,000, which is payable in shares of the Company in annual issuances over a period of two years. All shares issued pursuant to the acquisition are issued at a deemed price of $2.47 per share and are priced by calculating the 10-day volume-weighted average trading price of the Company's shares for the 10 trading days prior to the execution of the binding term sheet (Press release dated October 21, 2020). The shares will be subject to certain contractual restrictions on trading for a period of 16 months from the date of issuance. About CloudMD Software & Services CloudMD is digitizing the delivery of healthcare by providing a patient centric approach, with an emphasis on continuity of care. The Company offers SAAS based health technology solutions to healthcare providers across North America and has developed proprietary technology that delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, educational resources and artificial intelligence (AI). CloudMD currently services a combined ecosystem of over 500 clinics, almost 4000 licensed practitioners and 8 million patient charts across North America.ON BEHALF OF THE BOARD OF DIRECTORS “Dr. Essam Hamza, MD" Chief Executive Officer FOR ADDITIONAL INFORMATION CONTACT: Julia Becker VP, Investor Relationsjulia@cloudmd.ca Forward Looking Statements This news release contains forward-looking statements, including statements regarding projected revenue, completion of the CMD acquisition, future business synergies and cost savings. Such forward-looking statements are based on CloudMD’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including the expectations regarding closing of the CMD acquisition and the ability of the Company to carry out its business plans. Although CloudMD believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results, including revenue projections, may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and CloudMD undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law. Non-GAAP and Non-IFRS Measures This press release refers to “EBITDA” and “EBITDA margins” which are non-GAAP and non-IFRS financial measures that do not have a standardized meaning prescribed by GAAP or IFRS. The Company’s presentation of these financial measures may not be comparable to similarly titled measures used by other companies. These financial measures are intended to provide additional information to investors concerning the Company’s and CMD’s performance. EBITDA is defined as earnings before interest, taxes, depreciation and amortization and EBITDA margins is defined as EBITDA as a percent of total revenue. EBITDA and EBITDA margins are Non-IFRS measures the Company uses as an indicator of financial health and excludes several items which may be useful in the consideration of the financial condition of the Company and CMD, as applicable, including interest expense, income taxes, depreciation, and amortization. The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
Moderna (NASDAQ: MRNA) is about to make a boatload of money from its COVID-19 vaccine. In this Motley Fool Live video recorded on Jan. 13, 2021, healthcare and cannabis bureau chief Corinne Cardina and Fool.com writer Keith Speights discuss how big the market for Moderna's coronavirus vaccine could be. Corinne Cardina: Now, we are going to pivot into some deeper dives, into the three stocks that have a vaccine authorized in the U.S. Let's start with Moderna.
VANCOUVER, British Columbia, Jan. 22, 2021 (GLOBE NEWSWIRE) -- NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (NEO: NTAR.NE) (CSE: NTAR) (FSE: N29), a leading provider of virtual and augmented reality (AR) experience technologies and services for 3D/AR advertising, eCommerce, education, conferences and events today announced that it has sold its Bitcoin ownership of approximately 130.187 Bitcoins and booked approximately a $200,000 profit. NexTech CEO, Evan Gappelberg comments, “Our investment in Bitcoin in the past was part of our capital diversification strategy with the intent to maximize long-term value for our shareholders. This sale reflects our awareness that something potentially has changed with Bitcoin which is seen as the digital version of gold. The news that has emerged is that a critical flaw called a ‘double spend’ may have occurred, which if true allows someone to spend the same Bitcoin twice, undermining faith in the system. If the system is built on scarcity and faith in the system, then a ‘double spend’ would eliminate both -essentially destroying the store of value it was meant to be. In light of this potential outcome, I have decided to move to cash as this story is still unfolding.” Recent Company Highlights: January 20, 2021: The Company announced that Microsoft’s Azure Cloud Services platform will be a standard offering across its virtual experience platforms and consumer apps enabling hyper-scalable, secure, and immersive events and applications for users.January 15, 2021: Company has signed a renewal agreement with Poly with an initial value of $470,000 for a six-month term and the potential for additional revenue after the six months.Record Q4 2020 Total Bookings of $7.3 million +275% growth over the same period last yearCEO Evan Gappelberg purchased 250,000 shares. This purchase brings his 2020 purchased shares to 1,279,885 common shares of NexTech.Announced the launch of its groundbreaking “Genie in a Bottle” human hologram AR marketing platform and new eCommerce store for its TruLyfe brand of human supplements.Company graduated from the CSE and received approval to list its common shares with the NEO Exchange (“NEO”) senior exchange.Announced that it is expanding its services into the Asia-Pacific market after establishing a presence in Singapore. To support this expansion, NexTech has hired Yau Boon Lim, a technology industry veteran with over 25 years’ experience in strategy, planning, marketing, operations, and business management for various industries in the Asia Pacific market. Lim has held leadership positions within global enterprise technology companies, driving marketing and strategies for blue chip global tech companies, including IBM where he led marketing management, Motorola where he was Head of Strategy and Planning, and SAP where he was Vice President of Marketing for the Asia Pacific market. Lim is based out of Singapore.Coex chooses NexTech as its hybrid virtual event platform partner. Coex is a global leader in Meetings, Incentives, Conferences & Events (MICE); it hosts over 200 exhibitions and 3,000 meetings & events in-house each year in Korea at the Coex convention and exhibition center. Coex also organizes numerous exhibitions throughout Korea and abroad, with international reach in Vietnam, Indonesia, and China.Achieved a record-breaking 315% increase in Black Friday sales year-over-year across its AR eCommerce platform. With 2020 being a year dominated by coronavirus, shoppers have shown that they will embrace the convenience and safety of online shopping more than ever.The Canadian Society of Nephrology (CSN) has chosen NexTech AR’s Virtual Experience Platform (VXP) to host its 2021 Annual General Meeting, taking place May 10-13.Launched a new collaborative streaming solution with AI and AR enhancements, that integrates with its existing Virtual Experience Platform (VXP) and its ARitize SaaS offerings.Appointed Dr. David Cramb to its Board of Directors bringing its board to five members. Having this fifth board member allows the company to meet one of the NASDAQ requirements to qualify for its uplisting, which is in progress.Selected by TEDx Malmö for its first ever virtual event, held on December 12, 2020 in Sweden.A virtual concert featuring Grammy-nominated artist and member of Migos, Offset, in collaboration with the AXR+EXP concert series. The event was hosted via NexTech’s newly acquired AiRShow app.The United Nations Educational, Scientific and Cultural Organization (UNESCO) chose NexTech’s Virtual Experience Platform (VXP) for its “High-Level Futures Literacy Summit.”Restaurants Canada chose NexTech’s Virtual Experience Platform (VXP) platform to transform the 2021 RC Show, taking place February 28-March 3, 2021, into a completely virtual experience. This is Canada’s largest foodservice and hospitality event, the RC Show showcases cutting-edge products, pioneering people, and transformative ideas. About NexTech ARNexTech is one of the leaders in the rapidly growing Augmented Reality market estimated to grow from USD $10.7B in 2019 and projected to reach USD $72.7B by 2024 according to Markets & Markets Research; it is expected to grow at a CAGR of 46.6% from 2019 to 2024. The company is pursuing four verticals: Virtual Experience Platform (VXP): An advanced Augmented Reality and Video Learning Experience Platform for Events. VXP is a SaaS video platform that integrates Interactive Video, Artificial Intelligence and Augmented Reality in one secure platform to allow enterprises the ability to create the world’s most engaging virtual event management and learning experiences. Automated closed captions and translations to over 64 languages. According to Grandview Research the global virtual events market in 2020 is $90B and expected to reach more than $400B by 2027, growing at a 23% CAGR. With NexTech’s VXP platform having augmented reality, AI, end-to-end encryption, and built-in language translation for 64 languages, the company is well positioned to rapidly take market share as the growth accelerates globally. ARitize™ For eCommerce: The company launched its SaaS platform for webAR in eCommerce early in 2019. NexTech has a ‘full funnel’ end-to-end eCommerce solution for the AR industry including its Aritize360 app for 3D product capture, 3D/AR ads, its ARitize white label app, its ‘Try it On’ technology for online apparel, 3D and 360-degree product views, and ‘one click buy’. ARitize™ 3D/AR Advertising Platform: Launched in Q1 2020 the ad platform will be the industry's first end-to-end solution whereby the company will leverage its 3D asset creation into 3D/AR ads. In 2019, according to IDC, global advertising spend will be about $725 billion. ARitize™ Hollywood Studios: The studio is in development producing immersive content using 360 video, and augmented reality as the primary display platform. To learn more, please follow us on Twitter, YouTube, Instagram, LinkedIn, and Facebook, or visit our website: https://www.Nextechar.com. On behalf of the Board of NexTech AR Solutions Corp.“Evan Gappelberg”CEO and Director For further information, please contact: Evan GappelbergChief Executive Officerinfo@Nextechar.com The NEO has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. Certain information contained herein may constitute “forward-looking information” under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as, “will be”, “looking forward” or variations of such words and phrases or statements that certain actions, events, or results “will” occur. Forward-looking statements regarding the Company increasing investors awareness are based on the Company’s estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, levels of activity, performance, or achievements of NexTech to be materially different from those expressed or implied by such forward-looking statements or forward-looking information, including capital expenditures and other costs. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. NexTech will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
TORONTO, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Global design and technology firm, IBI Group Inc. (“IBI” or “the Company”), announced today the appointment of Michael Nobrega as its new Chair of the Board of Directors. Mr. Nobrega has been a Board Member with the firm for three years, and succeeds Dale Richmond, who retires from the Board effective today, and has served as Board Chair since 2014. The Company is currently undergoing a search to replace Mr. Nobrega’s now vacant Board Member position on its Board of Directors. “On behalf of the Board, senior management, and other stakeholders of the firm, I would like to thank Mr. Richmond for his dedicated years of service and strategic counsel. We are pleased to welcome Mr. Nobrega into his new role as Board Chair and look forward to working closely with him, and the other members of the Board, to achieve the goals and objectives of the firm over the coming years,” said IBI Group CEO, Scott Stewart. In addition to his new role as Board Chair for IBI, Michael Nobrega also sits on the Board of Toronto Hydro. He formerly held titles as Chair of the Ontario Centre of Innovation (OCI), interim President and CEO of Waterfront Toronto, President and CEO of OMERS, and President and CEO of Borealis Infrastructure. Mr. Nobrega holds an Honours BA in Economics and Mathematics from the University of Toronto, and is a Fellow of the Chartered Professional Accountants of Ontario. “IBI Group’s Board is diverse and talented, with members who have a wealth of knowledge and experience. My retirement as Chair provides the firm with an opportunity to further evolve the talent, diversity and experience of its Board of Directors, under the stewardship of my accomplished peer, Michael Nobrega, and the capable leadership of CEO Scott Stewart, CFO Stephen Taylor, President David Thom, and a host of talented young executives in each of the firm’s business segments. I will continue to maintain my current stock and debenture holdings in IBI Group for the foreseeable future,” said outgoing IBI Group Board Chair, Dale Richmond. “I have been a Director of IBI Group since 2004 and have witnessed the commitment and resolve of the Board and management to meet difficult challenges, including a global pandemic. I can say with conviction that the Board and management have exceeded my expectations. Today, IBI Group’s franchise is very strong and I have every confidence that its best years are ahead of it,” concluded Mr. Richmond. About IBI GroupIBI Group Inc. (TSX:IBG) is a technology-driven design firm with global architecture, engineering, planning, and technology expertise spanning over 60 offices and 2,700 professionals around the world. For nearly 50 years, its dedicated professionals have helped clients create livable, sustainable, and advanced urban environments. IBI Group believes that cities thrive when designed with intelligent systems, sustainable buildings, efficient infrastructure, and a human touch. Follow IBI Group on LinkedIn and Twitter. For additional information, please contact: Stephen Taylor, CFOIBI Group Inc.55 St. Clair Avenue WestToronto, ON M5V 2Y7Tel: 416-596-1930www.ibigroup.com For media inquiries: Julia HarperIBI Group Inc.Tel: firstname.lastname@example.org
DENVER, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, has been included in the first-ever Psychedelics Exchanged Traded Fund (ETF). The Horizons Psychedelic Stock Index ETF index, which was announced in December 2020 and includes 17 companies in the U.S. and Canada, is expected to start trading on Tuesday, January 26 under the ticker PSYK on the NEO exchange. “While medicinal psychedelics are certainly not new, the legal market and the ability to invest in these cutting-edge companies certainly is new,” said Joshua Bartch, Co-Founder & CEO, Mydecine. “Together, with these 17 companies, Mydecine is helping to build an industry that is investing in and researching innovative solutions for treating previously untreatable mental illness. We are honored that we are included, and we are also mindful that this now gives more people, who may be new to the space, the ability to access and diversify their investments. By having exposure to many different companies with solid fundamentals, but different approaches, philosophies, indications, and technologies, is healthy for investors in the industry.” The ETF will will track an underlying index – the North American Psychedelic Stock Index - provided by the German-based Solactive. Additional details on the ETF, including how it is weighted and conditioned, can be found here. Additionally, the Company will be participating in the KCSA Virtual Psychedelics Investor Conference, at 10:20 AM ET on Wednesday January 27, 2021. About Mydecine Innovations GroupMydecine Innovations Group™ (CSE: MYCO) (OTC:MYCOF) (FSE:0NFA) is an emerging biotech and life sciences company dedicated to developing and commercializing innovative solutions for treating mental health problems and enhancing vitality. The company’s world-renowned medical and scientific advisory board is building out a robust R&D pipeline of nature-sourced psychedelic-assisted therapeutics, novel compounds, therapy protocols, and unique delivery systems. Mydecine has exclusive access to a full cGMP certified pharmaceutical manufacturing facility with the ability to import/export, cultivate, extract/isolate, and analyze active mushroom compounds with full government approval through Health Canada. Mydecine also operates out of a state-of-the-art mycology lab in Denver, CO to focus on genetic research for scaling commercial cultivation of rare (non-psychedelic) medicinal mushrooms. At the heart of Mydecine’s core philosophy is that psychedelic-assisted psychotherapy will continue to gain acceptance in the medical community with many of the world’s best accredited research organizations demonstrating its remarkable clinical effectiveness. Mydecine recognizes the responsibility associated with psychedelic-assisted therapy and will continue to position itself as a long-term leader across the spectrum of clinical trials, research, technology, and global supply. Mydecine has also successfully completed multiple acquisitions since its inception. Learn more at: https://www.mydecine.com/ and follow us on Facebook, Twitter, and Instagram. Mydecine Innovations Group Media ContactsAnne Donohoe / Nick OpichKCSA Strategic Communicationsadonohoe@kcsa.com / email@example.com / 212-896-1206 On behalf of the Board of Directors:Joshua Bartch, Chief Executive Officercontact@mydecineinc.com Corp Communications:Charles Lee, Investor Relationscorp@mydecineinc.com+1 720-277-9879 For further information about Mydecine Innovations Group, Inc., please visit the Company’s profile on SEDAR at www.sedar.com or visit the Company’s website at www.mydecine.com. The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof. This news release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Readers are cautioned that these forward-looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected including, without limitation, the availability and continuity of financing, the ability of the Company to adequately protect and enforce its intellectual property, the Company's ability to bring its products to commercial production, continued growth of the global adaptive pathway medicine, natural health products and digital health industries, and the risks presented by the highly regulated and competitive market concerning the development, production, sale and use of the Company's products. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. These forward-looking statements are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required under applicable securities legislation. This news release does not constitute an offer to sell securities and the Company is not soliciting an offer to buy securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. This news release does not constitute an offer of securities for sale in the United States. These securities have not and will not be registered under United States Securities Act of 1933, as amended, or any state securities laws and may not be offered or sold in the United States or to a U.S. Person unless so registered, or an exemption from registration is relied upon.
Hilcorp Energy I, L.P. Announces Early Results of Dual Cash Tender Offers and Amendment of Offer for 2025 Notes
World Acceptance Corporation (NASDAQ: WRLD) today reported financial results for its third fiscal quarter and nine months ended December 31, 2020.
U.S. stock index futures slid from record levels on Friday as shares of blue-chip technology companies Intel and IBM tumbled following their quarterly results. IBM Corp slumped 7.4% and was the biggest loser among Dow components trading premarket after it missed estimates for quarterly revenue, hurt by a rare sales decline in its software unit. Intel Corp dropped about 4% as new Chief Executive Officer Pat Gelsinger signaled the lack of a strong embrace of outsourcing.
Both the S&P 500 and Nasdaq ended the regular trading day Thursday at record closing levels, and the Dow ended just short of its own record high.
The mineral insulated cable market was valued at US$ 951. 72 million in 2019 and is expected to grow at a CAGR of 5. 7% during the forecast period of 2020 to 2027 to reach US$ 1,337. 00 million by 2027.New York, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Mineral Insulated Cable Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type, Cladding, End-User Industry, and Geography" - https://www.reportlinker.com/p06010075/?utm_source=GNW The pharmaceutical industry is one of the key end users of mineral insulated cables, after energy, nuclear power plants, and oil & gas industries.In medical devices, these cables are used to ensure safer operations, as these devices need to comply with safety standards; any process variation can cause life-threatening issues.Therefore, mineral insulated cables are calibrated and verified on the basis of the National Institute of Standards and Technology (NIST) standards at OMEGA Engineering against known certified thermometers or other temperatures measurement instruments. The NIST confirms temperature accuracy under real operating conditions and provides documentation accordingly.In the pharmaceutical industry, cables developed for medical applications should be safe and reliable.Surgery robot systems, sterilization and disinfection, dental technology, imaging techniques, surgical lights, operation tables and treatment units, electro-surgical systems, electro-therapy devices, and laboratory equipment are among the medical applications where mineral insulated cables are used enormously.With the growing consumption of medical devices across hospitals, clinics, and laboratories, the scope of mineral insulated cable is also rising to ensure uninterrupted business in the pharmaceutical industry.The energy & power segment led the mineral insulated cables market based on end user industry in 2019.Temperature and pressure measurement instruments play a significant role in large-scale power plants, peak-load electricity generation plants, and decentralized systems in the energy & power sector.The use of temperature and pressure measurement instruments is further rising with the mounting number of gas turbine power plants; coal, gas, nuclear, hydro power, and thermal power stations; biogas plants; and wind power stations in the world to fulfill the ever-increasing demand for electricity. This factor is likely to fuel the adoption of mineral insulated cables in the temperature and pressure measurement applications in these facilities.The overall mineral insulated cables market size has been derived using both primary and secondary sources.To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market.The process also serves the purpose of obtaining overview and forecast for the mineral insulated cables market with respect to all the segments pertaining to the region.Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic.The participants of this process include industry expert such as VPs, business development managers, market intelligence managers, and national sales managers—along with external consultants such as valuation experts, research analysts, and key opinion leaders—specializing in the mineral insulated cables market. Bartec Top Holding GmbH, Raychem RPG Pvt Limited, Briskheat Corporation, eltherm GmbH, Emerson Electric Co., Thermocoax Group, Thermon Industries, Inc., MI Cable Technologies Inc., Trasor Corp., and Zhejiang Taisuo Technology Company, Ltd. are among a few players operating in the mineral insulated cables market.Read the full report: https://www.reportlinker.com/p06010075/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "Cranial Doppler Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to ResearchAndMarkets.com's offering. The report predicts the global cranial doppler market to grow with a CAGR of 6.7% over the forecast period from 2020-2026.The report on the global cranial doppler market provides qualitative and quantitative analysis for the period from 2018 to 2026. The study on the cranial doppler market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.The report on the cranial doppler market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cranial doppler market over the period of 2018 to 2026. Moreover, the report is the collective presentation of primary and secondary research findings.Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global cranial doppler market over the period of 2018 to 2026. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.What does this Report Deliver? Comprehensive analysis of the global as well as regional markets of the cranial doppler market.Complete coverage of all the segments in the cranial doppler market to analyze the trends, developments in the global market and forecast of market size up to 2026.Comprehensive analysis of the companies operating in the global cranial doppler market. The company profile includes analysis of product portfolio, revenue, SWOT analysis, and the latest developments of the company.Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand, and/or diversify. Report Findings1) Drivers The global rise in the number of geriatric patient's population suffering from a neurological disorderRecent expansion in the number of clinics for cerebrovascular diagnosis which provides various treatment methods 2) Restraints Lack of skilled expertise for diagnosis and treatment of a neurological disorder in some emerging countries 3) Opportunities Rising government support for research and development activities on cerebrovascular diagnosis and treatment Company Profiles Integra LifesciencesSpiegeberg GmbH &Co.Nihon Kohden CorporationElektaRimed Ltd.CAS Medical system, Inc.Atys MedicalShenzhen Delica Medical EquipmentNeural AnalyticsNatus Medical Key Topics Covered: 1. Preface1.1. Report Description1.2. Research Methods1.3. Research Approaches2. Executive Summary2.1. Cranial Doppler Market Highlights2.2. Cranial Doppler Market Projection2.3. Cranial Doppler Market Regional Highlights3. Global Cranial Doppler Market Overview3.1. Introduction3.2. Market Dynamics3.2.1. Drivers3.2.2. Restraints3.2.3. Opportunities3.3. Analysis of COVID-19 impact on the Cranial Doppler Market3.4. Porter's Five Forces Analysis3.5. Growth Matrix Analysis3.5.1. Growth Matrix Analysis by Type3.5.2. Growth Matrix Analysis by Application3.5.3. Growth Matrix Analysis by Region3.6. Value Chain Analysis of Cranial Doppler Market4. Cranial Doppler Market Macro Indicator Analysis5. Global Cranial Doppler Market by Type5.1. Imaging5.2. Non-Imaging6. Global Cranial Doppler Market by Application6.1. Sickle Cell Disease6.2. Acute Ischemic Stroke6.3. Intracranial Steno Occlusive Disease6.4. Others7. Global Cranial Doppler Market by Region 2020-20267.1. North America7.1.1. North America Cranial Doppler Market by Type7.1.2. North America Cranial Doppler Market by Application7.1.3. North America Cranial Doppler Market by Country7.2. Europe7.3. Asia-Pacific7.4. RoW8. Company Profiles and Competitive Landscape8.1. Competitive Landscape in the Global Cranial Doppler Market8.2. Companies Profiled Integra LifesciencesSpiegeberg GmbH &Co.Nihon Kohden CorporationElektaRimed Ltd.CAS Medical system, Inc.Atys MedicalShenzhen Delica Medical EquipmentNeural AnalyticsNatus Medical For more information about this report visit https://www.researchandmarkets.com/r/vo9zpm Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The global cannabis market could be worth as much as $47 billion in just four years. With incredible growth prospects and still only 15 states having legalized recreational marijuana, cannabis is one of the hottest industries out there right now. For investors who want a balanced and diverse portfolio, buying pot stocks makes a whole lot of sense, even if you're risk-averse.
The "Autonomous Ships Market by Autonomy (Fully Autonomous, Remote Operations, Partial Automation), Ship Type (Commercial, Defense), End-Use (Linefit, Retrofit), Solution (Systems, Software, Structures), Propulsion and Region - Global Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) -- The "Wood Coatings Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2020 To 2028" report has been added to ResearchAndMarkets.com's offering. The wood coatings function in protecting the wood structures from interior to exterior. Prevention from moisture penetration and severe climatic conditions necessitates wood coatings to ensure long term durability for its wood products. The growth in the construction activities coupled with the increase in spending power on repair and remolding is expected to drive the global wood coatings market.Among the system type, the solvent-borne segment accounted for a major value share in 2019 and expected to lose share gradually by 2028. This is attributed to harmful emissions through the use of organic solvents. However, the excellent finishing performance with technical advantages over others marks the solvent-borne wood coatings to still dominate in the market.Geographically, the Asia Pacific region registered a more than 45% value share in 2019 and expected to cater a significant growth by 2028. The government investments for the infrastructural development and initiatives towards housing schemes in countries such as India, Vietnam, and ASEAN countries among others, is expected to propel the wood coatings market in the region. In China, the demand for water-borne wood coatings is on rising owing to the new tax reform on VOC emissions. Some of the key players present in this market are Teknos Group Oy, BASF SE, Akzo Nobel N.V., The Sherwin-Williams Company, Valspar Corporation, Covestro AG, PPG Industries, Inc., Morrells Wood Finishes, Axalta Coating Systems, LLC, Katilac Coatings Inc. among others. Mergers/acquisition and new product launches, are some of the strategies the companies are undertaking to mark their robust presence in the global wood coatings market.The increased development in residential construction benefit wood coatings market, primarily for furniture, flooring, and decking end user. The furniture segment accounted value share of more than 25% followed by the flooring segment in 2019. The growing demand for high-quality and durable furniture products coupled with hard-wearing surfaces propels the wood coatings market for the furniture segment.The flooring and decking generally uses hardwood or engineered woods, which are the common choices for residential properties. The floorings are required to have slip resistance and durability for higher shelf life and thus drives the wood coating market for flooring and decking. However, the wood floorings are expensive, and their maintenance and replacements are also highly valued. Vinyl floor tiles with wooden floor styles are new substitutes in the market with much cheaper value than wood. Such a substitute for flooring & decking might impact the growth of the wood coating market. Key Topics Covered: Chapter 1 Preface1.1 Report Description1.2 Research Scope1.3 Research MethodologyChapter 2 Executive Summary2.1 Market Snapshot: Global Wood Coatings Market Revenue (US$ Bn)2.2 Global Wood Coatings Market Revenue (US$ Bn), by System Type2.3 Global Wood Coatings Market Revenue (US$ Bn), by Coating Type2.4 Global Wood Coatings Market Revenue (US$ Bn), by End User2.5 Global Wood Coatings Market Revenue (US$ Bn), by GeographyChapter 3 Global Wood Coatings Market Dynamics3.1 Overview3.2 Market Drivers3.3 Challenges3.4 Future Prospects3.5 Attractive Investment Proposition by Geography, 20193.6 Market Positioning of Key PlayersChapter 4 Global Wood Coatings Market, by System Type4.1 Overview4.2 Solvent-borne4.3 Water-borne4.4 High-solidsChapter 5 Global Wood Coatings Market, by Coating Type5.1 Overview5.2 Preservatives5.3 Stains & Varnishes5.4 Shellacs5.5 OthersChapter 6 Global Wood Coatings Market, by End User6.1 Overview6.2 Furniture6.3 Flooring6.4 Decking6.5 Siding6.6 OthersChapter 7 Global Wood Coatings Market, by Geography7.1 Overview7.2 Global Wood Coatings Market Revenue Share, by Geography, 2019 & 2028 (Value %)7.3 North America7.4 Europe7.5 Asia Pacific7.6 Latin America7.7 Middle East and Africa (MEA)Chapter 8 Company Profiles8.1 Teknos Group Oy8.2 BASF SE8.3 Akzo Nobel N.V.8.4 The Sherwin-Williams Company8.5 Valspar Corporation8.6 Covestro AG8.7 PPG Industries, Inc.8.8 Morrells Wood Finishes For more information about this report visit https://www.researchandmarkets.com/r/xr4eo Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The mobile crusher and mobile screener market was valued at US$ 2,958. 93 million in 2019 and is projected to reach US$ 4,919. 35 million by 2027; it is expected to grow at a CAGR of 6. 3% from 2020 to 2027.New York, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Mobile Crusher and Screener Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type and End User" - https://www.reportlinker.com/p06010076/?utm_source=GNW In the recent years, mobile crushers have been gaining increasing demand owing to the expansion of the construction industry.The major market players are expanding their current product portfolio, diversifying client base, and developing innovative products in the field of mobile crushers and screeners.The market is quite large at a global level with an increase in innovation to fulfill the need for innovative products and alternative fuel-run crushers and screeners that would ultimately reduce the carbon emission occurred due to use of diesel.Various companies in the value chain are entering into partnership with other players to maintain their position in the mobile crusher and mobile screener market and provide efficient solutions to their customers.Major manufacturers operating in the market are based in Europe and APAC.The market would grow rapidly in APAC and MEA, especially in countries such as India, China, the UAE, and South Korea in near future. Growing mining industry including mineral processing in these countries is one of the key factors driving the mobile crusher and screener market.Geographically, the mobile crusher and mobile screener market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East and Africa.Europe held the largest market share in 2019, followed by Asia Pacific and North America.Europe is experiencing rapid growth in infrastructure such as residential and commercial buildings, roads and highways, railways, and ports, which is expected to increase the utilization of mobile crushers and screeners in construction applications.The region has a presence of several leading companies such as Sandvik AB, Kleemann GmbH, and Metso.These companies are continuously engaged in various business activities such as new product development, merger and acquisition, and business expansion.Anaconda Equipment Ltd.; Astec Industries, Inc.; Komatsu Ltd.; Metso Corporation; Sandvik AB; Kleenmann GmbH (Wirtgen Group, a John Deere Company); Lippmann Division of Metso; McCloksey USA LLC; SBM Mineral Processing GmbH; Terex Corporation; and Thyssenkrupp AG are among the major players present in the global mobile crusher and mobile screener market.Impact of COVID-19 Pandemic on Mobile Crusher and Mobile Screener MarketThe COVID-19 outbreak was first reported in Wuhan, China, in December 2019.As of March 2020, the outbreak has adversely affected China, Italy, Iran, Spain, the Republic of Korea, France, Germany, and the US in terms of COVID-19 confirmed cases and reported deaths.The pandemic is hindering economies and industries in various countries owing to lockdowns, travel bans, and business shutdowns. The overall market and economical breakdown, factory shutdowns, and supply chain disruptions are restraining the growth of the mobile crusher and mobile screener market.Overall size of the global mobile crusher and mobile screener market has been derived in accordance to primary and secondary sources.To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market.Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the mobile crusher and mobile screener market.Read the full report: https://www.reportlinker.com/p06010076/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
The "Advanced Antibodies, 2020" report has been added to ResearchAndMarkets.com's offering.
Zidane will miss Real’s important trip to Alaves this weekend
The "5G Core Market by Component (Solutions and Services), Network Function (Access and Mobility Management Function, Policy Control Function, Unified Data Management), Deployment Model (Cloud and On-premises), End User, and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.